Patent Invalidity Screening

Patent Invalidity Screening

Early insight into patent strength and potential risk revealed.

What is patent invalidity screening?

Patent invalidity screening is an analytical process used to identify existing technical disclosures that may challenge the validity of an issued patent or patent application. It is commonly used when assessing patent strength, preparing for licensing discussions, or evaluating potential risks related to competitor patents.

Unlike patentability searches, invalidity screening focuses on finding earlier disclosures that could be relevant to specific claims of a patent. These disclosures may include patents, patent applications, or non-patent literature published before the patent’s priority date. The goal is to understand whether similar technical solutions were already known.

Our Patent Invalidity Screening service provides structured, non-legal analysis to support informed strategic and legal decision-making. We begin by reviewing the patent and its key technical features, followed by a targeted search focused on identifying highly relevant prior art. The results are summarized in a clear report highlighting documents that may be technically relevant to the patent claims.

This service does not provide legal conclusions regarding validity or enforceability. Instead, it equips clients and patent professionals with high-quality analytical input that can be used to assess risk, prepare legal strategies, or decide on next steps. Invalidity screening is often used early in disputes, licensing negotiations, or portfolio reviews to better understand patent strength.

Transparent Pricing

Choose the product that fits your needs. All packages include expert analysis and detailed reporting.

All prices are exclusive of VAT. VAT applies to customers established in the Netherlands.

Challenge patent validity with thorough prior art investigations and non-legal analysis.

Includes:

✅Rapid prior art identification

✅Novelty-destroying documents

✅Claim relevance mapping

✅Early risk assessment

Invalidity Screening

€1.800 – €2.500

Full Invalidity Study

€4.000 – €7.000

Challenge patent validity with thorough prior art investigations and non-legal analysis.

Includes:

✅Deep prior art search (patent + NPL)

✅Claim-by-claim analysis

✅Document relevance ranking

✅Clear invalidity arguments (non-legal)

✅Structured attorney-ready report

FAQs

1. What is patent invalidity screening?

It is an analytical search for earlier technical disclosures that may be relevant to assessing the strength or validity of a patent.

2. Is invalidity screening the same as a legal invalidity opinion?

No. This service is non-legal and does not provide legal opinions or conclusions.

3. Who typically uses invalidity screening?

Patent attorneys, companies, investors, and licensing teams commonly use invalidity screening as part of risk assessment or strategic planning.

4. What types of documents are searched?

We analyze patents, patent applications, and relevant non-patent literature published before the patent’s priority date.

5. Does the screening focus on specific claims?

Yes. The analysis typically targets key claims or technical features of the patent.

6. How are the results presented?

Results are delivered in a structured report explaining why identified documents may be technically relevant.

7. How long does an invalidity screening take?

Most screenings take one to three weeks, depending on patent complexity and scope.

8. Can this be used in litigation?

The analysis can support preparation and strategy but does not replace legal analysis or expert opinions.

9. What if no strong prior art is found?

That insight is still valuable, as it helps assess patent strength and risk.

10. Can this service be combined with other analyses?

Yes. Invalidity screening is often combined with FTO support, licensing analysis, or portfolio reviews.

Ready to Get Started?

Let's discuss how our patent analysis services can support your innovation strategy.

IPnalytix supports clients across medical devices, consumer electronics, and telecommunications.